Why More Patients are Turning to Adventist Health Glendale for Advanced Heart Valve Care
Adventist Health Glendale completed its 800th transcatheter aortic valve replacement (TAVR) procedure in March 2026, marking a significant milestone for its structural heart program and underscoring the continued expansion of advanced valve care in a community setting.
Since performing its first TAVR in 2016, the program has developed into one of the region’s high-volume structural heart platforms, supported by experienced interventional cardiologists, multidisciplinary case review, advanced imaging, and peri-procedural coordination.
TAVR has become a well-established treatment option for patients with severe symptomatic aortic stenosis across a broad range of surgical risk profiles. At Adventist Health Glendale, the program’s growth reflects both increasing referral confidence and the institution’s ability to evaluate and manage complex cases using a minimally invasive approach.
“Reaching 800 TAVR procedures is an important milestone for our team and for the patients and physicians who trust us with their care,” said Dr. Harry Balian, Medical Director of Cardiovascular Services at Adventist Health Glendale. “It reflects years of programmatic investment, clinical experience, and strong multidisciplinary collaboration. Our focus remains on identifying appropriate candidates, delivering high-quality outcomes, and ensuring patients can access advanced structural heart treatment close to home.”
In addition to TAVR, Adventist Health Glendale continues to expand its structural heart capabilities through other catheter-based therapies for complex valvular and cardiovascular disease.
Referrals:
Physicians seeking evaluation for patients with severe aortic stenosis or other structural heart conditions may refer to Adventist Health Glendale’s structural heart program may call 818-409-8100.